Oct 25, 2022 - Oct 29, 2022
Los Angeles, CA

Jump to:

For four decades, we’ve been at the forefront of innovation in genomics and genetic research. Throughout that time, we’ve remained dedicated to delivering technologies that enable you to better understand human disease and health. This year, we are celebrating the 40th anniversary of providing high-quality Applied Biosystems products and services to our customers. While you’re at ASHG, we invite you to visit our scientific talks and posters, and don't forget to visit us at Booth 1515 to receive a 40th anniversary giveaway package* and have the opportunity to meet with our genetic experts (you can request a meeting below).

Request meeting

Featured genetic technologies


SeqStudio Flex Genetic Analyzer

Maximum flexibility meets trusted performance. Streamline your lab workflow with end-to-end Sanger sequencing and fragment analysis solutions.


QuantStudio Absolute Q Digital PCR System

Precision and speed to put you above the curve. Powerfully simple digital PCR for absolute quantification of genetic targets.


Applied Biosystems Axiom microarrays

Trust earned in the lab. Proven microarray solutions are a versatile tool that provides valuable and comprehensive insights across gene pathways and biomarker classifications.


QuantStudio Real-Time PCR systems

Simplify your workflow with gold-standard qPCR innovation. Discover comprehensive solutions for sensitive, specific detection and quantification of nucleic acid.

Educational sessions

Session 1: Industry workshop (lunch provided)

Title: Genetic analysis tools for precision cancer research

Steve Jackson, Associate Director Applications, Thermo Fisher Scientific
Archana Gupta, Staff Scientist Applications, Thermo Fisher Scientific
Marcia Slater, Technical Sales Specialist. Thermo Fisher Scientific

Conquering cancer through precision medicine relies on a deep understanding of various associated genetic defects.  In this session we will illustrate how the Applied Biosystems portfolio of genetic analysis systems are being used in precision cancer research.  We will show how these tools are used to understand microsatellite instability, epigenetic modifications, and other biomarkers, verification and study of pathogenic alleles in tumors and liquid biopsy samples, and uses in cancer vaccine development.  We will show how these tools can work together to provide optimal depth-of-knowledge about cancer genetic problems. 

Date/time: Thursday, October 27, 12:30–1:30 pm
Room: 303A+B

Session 2: Co-lab 

Title: Panel Discussion: Obstacles & Outcomes of Predictive Genomics in Precision Medicine

Jeanette Schmidt, Ph.D., Sr. Director of Bioinformatics, Thermo Fisher Scientific​
Andy Peterson, CEO, Broadwing Bio
Solomon M. Adams, PharmD, PhD, Director of Bioinformatics and Genomic Services, Ariel Precision Medicine

Among the measurable factors that contribute to overall health, 25% is linked to genetics making predictive genomics for personalized medicine more critical than ever before. Predictive genomics helps identify disease risks with polygenic risk scores (PRSs) and manage adverse drug responses (ADRs) with pharmacogenomics (PGx). Our understanding of PRS and PGx will significantly change personalized and population health management in the future. Join us for a panel discussion on the future of predictive genomics to learn how predictive genomics is disrupting the healthcare landscape.

Date/time: Thursday, October 27, 3:45 PM
Room: Theater 3

Session 3: Co-lab 

Title: Optimize your genetic workflow by leveraging breakthrough technologies: dPCR, Sanger sequencing & Fragment Analysis

Marcia Slater, Technical Sales Specialist. Thermo Fisher Scientific
Chris Willis, Field Application Specialist, Thermo Fisher Scientific

Join us to discover two critical genetic analysis technologies from the Applied Biosystems portfolio: dPCR for reliable absolute quantification of nucleic acid targets and capillary electrophoresis for targeted sequence interrogation using fragment analysis and Sanger sequencing. Learn about the optimized workflows of the new Applied Biosystems SeqStudio Flex Genetic Analyzer and QuantStudio Absolute Q Digital PCR System in clinical research applications in cancer and human genetics.

Date/time: Wednesday, October 26, 12:30 pm
Room: Theater 3


Plan on attending our poster presentations during the ASHG 2022 annual meeting to see how you can apply different genetic technologies to better understand human disease and health.


Poster #

A method for ABO genotyping by Sanger DNA sequencing


A simple workflow for methyl DNA analysis in FFPE-preserved Alzheimer and other neurodegenerative brain samples


Algorithmic and Assay-based Simplification of Multiallelic Variants for Genotyping


Comparison of genotyping arrays and low-pass sequencing for predictive genomics research


 High-Throughput Sample Processing workflow for rapid Vaginal microbiota profiling of women’s health samples.


Improved genotyping of rare variants from AppliedBiosystems Axiom microarrays, using Support Vector Machine (SVM) prediction models.


Understanding the molecular basis of SARS-CoV-2 pathogenesis at a gene expression level using Applied Biosystems TaqMan Flexible Array Panels


* No purchase necessary. This promotion is available only to life science professionals 21 years or older who are attendees (excluding vendors) of ASHG 2022 who allow us to scan their ASHG badge. The badge must be scanned no later than October 26th or until gift supplies are depleted, whichever comes first. The estimated value of the cooke, tshirt and poster is [$8] USD. One free gift per person. By allowing us to scan your badge, you warrant that you are not prohibited by employment, contract, or law from accepting a gift from Life Technologies. Offer void in where prohibited, licensed or restricted by federal, state, provincial, or local laws or regulation or agency/institutional policy. Other restrictions may apply.

For Research Use Only. Not for use in diagnostic procedures.